Altona Rare Earths shares jump 11% as gallium results exceed expectations at Mozambique project
Amplia flags key ACCENT milestone as 5 complete responses sharpen narmafotinib case in pancreatic cancer
X‑Energy files to go public on the Nasdaq, eyes $300M raise
Amplia Therapeutics Limited to Present at the Life Sciences Virtual Investor Forum December 11th